CE vs THAR · rev $10.28B vs $187.4M cap
Celanese Corporation (CE) versus Tharimmune Inc. (THAR) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Tharimmune Inc. (THAR) is a biotechnology company listed on NASDAQ.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
THAR does not have a complete income-statement cache yet.
CE currently screens at market cap $5.92B. THAR currently screens at market cap $187.4M.
Not investment advice. Open the CE and THAR stock pages for the full models.
Not investment advice.